This prospective multicentre phase II study evaluated targeted microwave ablation (TMA) using OBT Fusion in men with localised intermediate-risk prostate cancer, showing 81% of ... Read the study
Yee et al. Buji. 2025 March
Our study reported the outcome of a multi-modality focal therapy (FT) cohort for localized primary prostate cancer. Read the study
Chi Hang Yee et al. Buji. 2025 Feb
Cryotherapy as one of the most established focal therapy tools has demonstrated satisfactory oncological and fu... Read the study
Chiu et al. 2024 Dec
Targeted microwave ablation (TMA) is a novel focal therapy modality for prostate cancer (PC). TMA-HK is the first phase 2 tri... Read the study
Bourgeno et al. 2024 Dec
Systematic biopsy (SB) combined with magnetic resonance imaging (MRI)-targeted biopsy is still recommended considering th... Read the study
Oderda et al. 2024 Nov
Targeted microwave ablation (TMA) is a novel modality of focal therapy to treat localized prostate cancer (PCa). We evaluat... Read the study
Storino Ramacciotti et al. 2024 Sept
To compare transperineal (TP) vs transrectal (TR) magnetic resonance imaging (MRI) and transrectal ultrasound... Read the study
Oderda M et al. World J Urol. 2024 Sept
To evaluate biopsy-related complications and detection rates of any PCa and clinically significant PCa (cs... Read the study